Overview

D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients

Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of dexmethylphenidate (d-MPH) in the treatment of chemotherapy-related fatigue in adult cancer subjects.
Phase:
Phase 2
Details
Lead Sponsor:
Celgene Corporation
Treatments:
Dexmethylphenidate Hydrochloride